BioNTech SE (BNTX) at a glance

BioNTech SE (BNTX) is a large-cap Healthcare company. It trades at $97.6, with a P/E of 160.8, a -44.6% profit margin and revenue decline of 35.4%. It does not pay a dividend. Vestovix scores it 30/100 overall. Its strongest dimension is Safety (52/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$97.60

Market cap

$22.90B

P/E ratio

160.8

Dividend yield

None

Beta

1.32

52-week range

$79.52 to $124.00